/
RenovoRx, Inc.
RenovoRx, Inc., a clinical-stage biopharmaceutical company, engages in developing targeted combination therapies to improve therapeutic outcomes for cancer patients undergoing treatment.
Mentions
1 mention · latest on 25 Aug 2026
See which tracked investors hold RenovoRx, Inc. →Ownership and position changes on OwnershipTrace